Français
ItalianoBond Viatris 2.7% ( US91533BAD29 ) in USD
| Issuer | Viatris | ||||||||
| Market price |  100.00 % ⇌ |
||||||||
| Country |  United States
|
||||||||
| ISIN code |
 US91533BAD29 ( in USD )
|
||||||||
| Interest rate | 2.7% per year ( payment 2 times a year) | ||||||||
| Maturity | 22/06/2030 | ||||||||
|
Prospectus brochure in PDF format |
|||||||||
| Minimal amount | 2 000 USD | ||||||||
| Total amount | 1 450 000 000 USD | ||||||||
| Cusip | 91533BAD2 | ||||||||
| Standard & Poor's ( S&P ) rating | BB+ ( Non-investment grade speculative ) | ||||||||
| Moody's rating | Baa3 ( Lower medium grade - Investment-grade ) | ||||||||
| Next Coupon | 22/12/2026 ( In 94 days ) | ||||||||
| Detailed description |
Global healthcare company formed from the merger of Mylan and Upjohn. The Bond issued by Viatris ( United States ) , in USD, with the ISIN code US91533BAD29, pays a coupon of 2.7% per year. The coupons are paid 2 times per year and the Bond maturity is 22/06/2030 The Bond issued by Viatris ( United States ) , in USD, with the ISIN code US91533BAD29, was rated Baa3 ( Lower medium grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by Viatris ( United States ) , in USD, with the ISIN code US91533BAD29, was rated BB+ ( Non-investment grade speculative ) by Standard & Poor's ( S&P ) credit rating agency. |
||||||||
| |||||||||